Pionyr Immunotherapeutics Stock

www.pionyrtx.comHealthcareFounded: 2015

Pionyr Immunotherapeutics develops cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity and ability to combat cancer.

Register for Details

For more details on financing and valuation for Pionyr Immunotherapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Pionyr Immunotherapeutics.

Register Today

Other companies like Pionyr Immunotherapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B